Convective renal replacement therapies for acute renal failure and end-stage renal disease

Hemodialysis International

Volumn 8, Issue 4, 2004, Pages 386-393

  Huang, Zhongping ^a   Li, Baochun ^b   Zhang, Weiming ^c   Gao, Dayong ^d   Kraus, Michael A ^e   Clark, William R ^e,f  

^a WIDENER UNIVERSITY   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d University of Washington   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

Hemodiafiltration; Hemodialysis; Hemofiltration; Solute; Ultrafiltration

Indexed keywords

UREMIC TOXIN;

ACUTE KIDNEY FAILURE; CLEARANCE; CONCENTRATION (PARAMETERS); CRITICAL ILLNESS; DIFFUSION; EVIDENCE BASED MEDICINE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; MATHEMATICAL COMPUTING; MEMBRANE FILTER; MEMBRANE PERMEABILITY; OUTCOMES RESEARCH; POLARIZATION; REVIEW; SURVIVAL RATE; ULTRAFILTRATION;

EID: 21644459442     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2004.80415.x     Document Type: Review

References (61)

1. Henderson LW. The problem of peritoneal membrane area and permeability. Kidney Int. 1973; 3(6): 409-410.
2. Lowrie EG, Steinberg SM, Galen MA, Gagneux SA, Lazarus JM, Gottlieb MN, Merrill JP. Factors in the dialysis regimen which contribute to alternations in the abnormalities of uremia. Kidney Int. 1976; 10(5): 409-422.
3. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med. 1981; 305(20): 1176-1181.
4. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985; 28(3): 526-534.
5. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993; 329(14): 1001-1006.
6. Parker TF 3rd, Husni L, Huang W, Lew N, Lowrie EG. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis. 1994; 23(5): 670-680.
7. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis survival. Am J Kidney Dis. 1994; 23(2): 272-282.
8. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994; 23(5): 661-669.
9. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996; 7(2): 198-207.
10. Teehan B, Schleifer C, Brown J, Sigler MH, Raimondo J. Urea kinetic analysis and clinical outcomes on CAPD: A five year longitudinal study. Adv Perit Dial. 1990; 6: 181-185.
11. Genestier S, Hedelin G, Schaffer P, Faller B. Prognostic factors in CAPD patients: A retrospective study of a 10-year period. Nephrol Dial Transplant. 1995; 10(10): 1905-1911.
12. NKF-DOQI. Clinical practice guidelines for hemodialysis adequacy: Update 2000. Am J Kidney Dis. 2001; 37(Suppl 1): S7-S64.
13. NKF-DOQI. Clinical practice guidelines for peritoneal dialysis adequacy: Update 2000. Am J Kidney Dis. 2001; 37(Suppl 1): S65-S136.
14. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347(25): 2010-2019.
15. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002; 13(5): 1307-1320.
16. Clark WR, Winchester JW. Middle molecules and small molecular weight proteins in ESRD: Properties and strategies for their removal. Adv Renal Replace Ther. 2003; 10: 270-278.
17. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol. 1994; 4(7): 1413-1420.
18. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol. 1997; 8(5): 804-812.
19. Liao Z, Zhang W, Poh CK, Huang Z, Hardy PA, Kraus MA, Clark WR, Gao D. Kinetic comparison of different acute dialysis therapies. Artif Organs. 2003; 27(9): 802-807.
20. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M, Lee JC, Moreno L, Sakai K. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis. 1996; 28(Suppl 3): S81-S89.
21. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002; 346(5): 305-310.
22. Ronco C, Bellomo, R, Hommel P, Brendolan A, Dan M, Piccinni P, LaGreca G. Effects of different doses in continuous veno-venous hemofiltration on outcomes in acute renal failure: A prospective, randomized trial. Lancet. 2000; 355: 26-30.
23. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In Jacobs C, ed. Replacement of Renal Function by Dialysis, 4th ed. Dortdrecht: Kluwer Academic, 1996; 114-118.
24. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D. Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int. 1986; 30(3): 429-432.
25. Kim ST. Characteristics of protein removal in hemodiafiltration. Contr Nephrol. 1994; 108: 23-37.
26. Ofsthun NJ, Zydney AL. Importance of convection in artificial kidney treatment. Contrib Nephrol. 1994; 108: 53-70.
27. Clark WR, Macias WL, Molitoris BA, Wang NHL. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int. 1995; 48(2): 481-487.
28. Langsdorf LJ, Zydney AL. Effect of blood contact on the transport properties of hemodialysis membranes: A two-layer model. Blood Purif. 1994; 12: 292-307.
29. Morti SM, Zydney AL. Protein-membrane interactions during hemodialysis: Effects on solute transport. ASAIO J. 1998; 44(4): 319-326.
30. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol. 2002; 13(Suppl 1): S41-S47.
31. Clark WR, Gao D. Properties of membranes used for hemodialysis therapy. Semin Dial. 2002; 15(3): 1-5.
32. Henderson LW. Pre vs post dilution hemofiltration. Clin Nephrol. 1979; 11(2): 120-124.
33. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med. 1974; 291(15): 747-751.
34. Henderson LW, Colton CK, Ford CA, Lysaght MJ. Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med. 1975; 85: 372-391.
35. Colton CK, Henderson LW, Ford C, Lysaght MJ. Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med. 1975; 85(3): 355-371.
36. Clark WR, Gao D. Determinants of small solute clearance in hemodialysis. Semin Dial. 2004; in press.
37. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular weight proteins: A review. Kidney Int. 1979; 16: 251-270.
38. Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int. 1978; 14(5): 522-525.
39. Shaldon S, Beau MC, Deschodt G, Delise Nichols HF, Oules R, Ramperez P, Mion C. Economic preparation of sterile non-pyrogenic infusate for hemofiltration. Dial Transplant. 1983; 12: 792-793.
40. Canaud B, N'Guyen QV, Lagrarde C, Stec F, Polaschegg HD, Mion C. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for post-dilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol. 1985; 46: 184-186.
41. Ledebo I. Principles and practice of hemofiltration and hemodiafiltration. Artif Organs. 1998; 22(1): 20-25.
42. Ofsthun NJ, Colton CK, Lysaght MJ. Determinants of fluid and solute removal rates during hemofiltration. In: Henderson LW, Quellhorst EA, Baldamus CA, Lysaght MJ, eds. Hemofiltration. Berlin: Springer-Verlag, 1986; 18-39.
43. Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs. 2003; 27(9): 815-820.
44. Ahuja A, Rodby R, Huang Z, Gao D, Zhang W, Clark WR. Effect of pre-dilution replacement fluid administration on solute clearance in high-volume hemofiltration [abstract]. J Am Soc Nephrol. 2003; 14: 734A.
45. Shinaberger J, Miller J, Gardner P. Erythropoietin alert: Risks of high hematocrit hemodialysis. ASAIO Trans. 1988; 34(3): 179-184.
46. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care. 2002; 17(4): 246-250.
47. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schutterle G. Simultaneous hemofiltration/hemodialysis: An effective alterantive to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol. 1978; 9(3): 115-121.
48. Kunitomo T, Kirkwood RG, Kumazawa S, Gottlieb MN, Lowrie EG. Clinical evaluation of postdilution dialysis with a combined ultrafiltration (UF)-hemodialysis (HD) system. Trans Am Soc Artif Intern Organs. 1978; 24: 169-177.
49. Ledebo I. On-line hemodiafiltration: Technique and therapy. Adv Renal Replace Ther. 1999; 6(2): 195-208.
50. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Alberto MD, Calvo C, Torregrosa I, Navarro V. Change from conventional hemodiafiltration to on-line hemodiafiltration. Nephrol Dial Transplant. 1999; 14(5): 1202-1207.
51. Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, Mion C. On-line hemodiafiltration: Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant. 2000; 15(Suppl 1): 60-67.
52. Wizemann V, Lotz C, Techert F, Uthoff S. On-line hemodiafiltration versus low-flux haemodialysis: A prospective randomized study. Nephrol Dial Transplant. 2000; 15(Suppl 1): 43-48.
53. Ono M, Taoka M, Takagi T, Ogawa H, Saito A. Comparison of types of on-line hemodiafiltration from the standpoint of low-molecular-weight protein removal. Contrib Nephrol. 1994; 108: 38-45.
54. Ahrenholz P, Winkler RE, Ramlow W, Tiess M, Muller W. On-line hemodiafiltration with pre- and post-dilution: A comparison of efficacy. Int J Artif Organs. 1997; 20(2): 81-90.
55. Hillion D, Haas T, Pertuiset N, Uzan M. Pre-/postdilution hemofiltration. Blood Purif. 1995; 13(5): 241-245.
56. Pedrini LA, De Christofaro V, Pagliari B, Sama F. Mixed predilution and post-dilution online hemodiafiltration compared with traditional infusion modes. Kidney Int. 2000; 58(5): 2155-2165.
57. Werynski A, Waniewski J. Theoretical description of mass transport in medical membrane devices. Artif Organs. 1995; 19(5): 420-427.
58. Jaffrin M. Convective mass transfer in hemodialysis. Artif Organs. 1995; 19(11): 1162-1171.
59. Henderson LW, Leypoldt JK, Lysaght MJ, Cheung AK. Death on dialysis and the time/flux trade-off. Blood Purif. 1997; 15(1): 1-14.
60. Sigler MH, Teehan BP. Solute transport in continous hemodialysis: A new treatment for acute renal failure. Kidney Int. 1987; 32(4): 562-571.
61. Brunet S, Leblanc M, Geadah D, Parent D, Corteau S, Cardinal J. Diffusive and convective solute clearance during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis. 1999; 34(3): 486-492.